Healthcare & Life Sciences
Highlight Therapeutics
Highlight Therapeutics is a Healthcare & Life Sciences startup based in Spain, most recent round Series C+, 2 tracked investors.
Activeseries-c-plus
series-c-plus
Stage
2018
Founded
2
Investors
About Highlight Therapeutics
Highlight Therapeutics is a company founded in 2018 headquartered in Spain. Its most recent tracked round is Series C+. Brouky classifies it under Healthcare & Life Sciences. Brouky records 2 investors associated with the company.
Highlight Therapeutics is a clinical-stage biotechnology company developing a new class of RNA-based drugs (DRP) for cancer treatment. Their lead product, BO-112, targets solid tumors like melanoma, lung, and liver cancer.
Explore Highlight Therapeutics's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.